# FDA Inspection 1125025 - Joanne Kurtzberg MD - July 02, 2020

Source: https://www.keypedia.com/records/fda_inspections/joanne-kurtzberg-md/17101c3d-c4e2-4d1c-ba9d-94c8358e0b42
Source feed: FDA_Inspections

> FDA Inspection 1125025 for Joanne Kurtzberg MD on July 02, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1125025
- Company Name: Joanne Kurtzberg MD
- Inspection Date: 2020-07-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1175241 - 2022-06-30](https://www.keypedia.com/records/fda_inspections/joanne-kurtzberg-md/19db2382-b1a3-4ccc-9cb3-b491d64f1361)
- [FDA Inspection 1125025 - 2020-07-02](https://www.keypedia.com/records/fda_inspections/joanne-kurtzberg-md/4ba1ab3e-fc81-46f1-9b81-f7ad3b2ed5e8)

Company: https://www.keypedia.com/companies/joanne-kurtzberg-md/3d123642-3863-4a4f-8198-c0ef574b7851

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d